Insulet (PODD) EBITDA Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Insulet (PODD) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | -497.00 |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 314.00 |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 124.00 |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | 670.00 |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 546.00 |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | 264.00 |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | -919.00 |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 595.00 |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 146.00 |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | -248.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -248.00 |
| Mar 31, 2026 | 42.00 |
| Dec 31, 2025 | 37.00 |
| Sep 30, 2025 | 47.00 |
| Jun 30, 2025 | 750.00 |
| Mar 31, 2025 | 272.00 |
| Dec 31, 2024 | -260.00 |
| Sep 30, 2024 | 353.00 |
| Jun 30, 2024 | 331.00 |
| Mar 31, 2024 | 515.00 |
| Dec 31, 2023 | 1,453.00 |
| Sep 30, 2023 | 1,181.00 |
| Jun 30, 2023 | 1,676.00 |
| Mar 31, 2023 | -509.00 |
| Dec 31, 2022 | -980.00 |
| Sep 30, 2022 | -1,138.00 |
| Jun 30, 2022 | -1,891.00 |
| Mar 31, 2022 | 637.00 |
| Dec 31, 2021 | 1,912.00 |
| Sep 30, 2021 | 206.00 |